GSK : announces positive results from phase III severe asthma trials of depemokimab - Form 6-K
A1901p UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
Source: marketscreener.com
📰 Steph Mountifield News
Steph Mountifield News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Steph Mountifield. Real-time updates on events, politics, business and more.
GSK : completes sale of remaining shares in Haleon - Form 6-K
A8223o UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER...
Source: marketscreener.com
GSK announces intention to sell shares in Haleon | Company Announcement
Investegate announcements from GSK announces intention to sell shares in Haleon
Source: investegate.co.uk
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
DURHAM, N.C.--(BUSINESS WIRE)--Apr 8, 2024--
Source: eagletribune.com
Investegate | Company Announcement
Investegate announcements from EMA accepts Arexvy filing for adults 50-59 at risk
Source: investegate.co.uk
GSK : Jemperli (dostarlimab) plus Zejula (niraparib) combination significantly improved progression-free survival in primary advanced or recurrent endometrial cancer in RUBY Part 2 Phase III trial - Form 6-K -December 18, 2023 at 06:38 am EST
A1192x UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER...
Source: marketscreener.com
GSK : Japan's Ministry of Health, Labour and Welfare accepts Arexvy regulatory application to prevent RSV disease in adults aged 50-59 at increased risk - Form 6-K -December 12, 2023 at 06:09 am EST
A3878w UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER...
Source: marketscreener.com
GSK : Phase III RUBY trial of Jemperli (dostarlimab) plus chemotherapy meets endpoint of overall survival in patients with primary advanced or recurrent endometrial cancer - Form 6-K -October 30, 2023 at 07:13 am EDT
A6268r UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER...
Source: marketscreener.com
GSK : ViiV Healthcare receives approval from China's National Medical Products Administration (NMPA) for Vocabria (cabotegravir) used in combination with Rekambys (rilpivirine), the first and only complete long-acting HIV-1 injectable treatment - Form 6-K -October 26, 2023 at 08:20 am EDT
A3337rgskplcedgar UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington,...
Source: marketscreener.com
GSK : THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE, TRANSMISSION DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION - Form 6-K -October 06, 2023 at 02:22 pm EDT
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER...
Source: marketscreener.com